Codex DNA jumps on deal with Pfizer

Telesis Bio

10/01/2022 12:16

** DNA printer maker Codex DNA  DNAY.O  jumps 22% premarket
to $11.43, set to open at a three-month high
    ** DNAY strikes licensing agreement for Pfizer to use co's
enzymatic DNA synthesis (EDS) technology in its research and
development of mRNA-based vaccines and biotherapies  urn:newsml:reuters.com:*:nB8N2JW0D2
    ** DNAY's short oligo ligation assembly EDS is a
patent-pending research approach aimed at faster construction of
synthetic DNA, RNA and protein
    ** Co says apart from upfront payment from Pfizer, DNAY to
get milestone payments in excess of $100 mln 
    ** As of last close, DNAY was down ~50% since June debut
price of $20
    

 (Reporting by Susan Mathew)
 ((susan.mathew@thomsonreuters.com))